PlainPharmaWatch

CMS Open Payments · Program Year 2024

NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation reported $44,745.31 across General Payments, Research, and Ownership to 40 physicians and teaching hospitals across 40 transactions.

See the rankings → How this is sourced
$44.7K
All-tracks total
40
Transactions
40
Recipients
−$53.3K
General Payments vs PY2023

NeuroOne Medical Technologies Corporation reported $44,745.31 across all CMS Open Payments tracks (General + Research + Ownership) to 40 physicians and teaching hospitals in Program Year 2024 - ranking #1380 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $44,745.31, averaging $1.1K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer neuroone-medical-technologies-corporation NeuroOne Medical Technologies Corporation

$44.7K · #1380/1,925 · 0.0% industry · PY2024

  • TOT $44.7K
  • RANK #1380
  • SHARE 0.0%
  • TXN 40
  • RCP 40
  • CAT 2
  • GEN $44.7K
  • ΔGEN −$53.3K
  • TOP1 33.4%
  • PY 2024

Volume peers

Nearest volume peer: CMS Imaging, Inc. ($44.5K)

Zyla Life Sciences, Inc.$45.0KNeuroOne Medical Technologie…$44.7KCMS Imaging, Inc.$44.5KOptumHealth Care Solutions, …$44.5KWhitehall International Inc$44.4K
All-tracks payment totals near NeuroOne Medical Technologies Corporation (CMS Open Payments PY2024)

NeuroOne Medical Technologies Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

NeuroOne Medical Technologies Corporation's CMS-reported General Payments decreased by $53.3K (−54.4%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: NEUROONE MEDICAL TECHNOLOGIES CORPORATIONPY2023: NEUROONE MEDICAL TECHNOLOGIES CORPORATIONPY2024: NeuroOne Medical Technologies Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$98.0KPY2024$44.7K
PY2023
$98,041.83
PY2024
$44,745.31

What the Data Shows for NeuroOne Medical Technologies Corporation

In Program Year 2024, NeuroOne Medical Technologies Corporation reported $44,745.31 in payments to 40 physicians and teaching hospitals across 40 individual transactions, an average of $1.1K per transaction and $1.1K per recipient. That total places NeuroOne Medical Technologies Corporation at rank #1380 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $41.3K across 21 transactions, 92.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, NeuroOne Medical Technologies Corporation's largest category was "Consulting Fee" at $41.3K - 92.2% of General Payments.

How NeuroOne Medical Technologies Corporation divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$41.3K2. Food and Beverage$3.5K
Payment Type Amount Transactions
Consulting Fee $41.3K 21
Food and Beverage $3.5K 19

Recipient Concentration in General Payments

The five largest recipient relationships account for $38,596.91 (86.3%) of $44,745.31 in this company's General Payments records across 15 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for NeuroOne Medical Technologies Corporation

The five named recipients with the highest reported General Payments from this company

Robert Gross$14.9KChengyuan Wu$7.8KDavid Darrow$6.0KParag Patil$5.4KAnthony Berg$4.5K
  1. 1

    Robert Gross

    $14,939.82 across 4 reported transactions

  2. 2

    Chengyuan Wu

    $7,804.15 across 3 reported transactions

  3. 3

    David Darrow

    $5,993.97 across 6 reported transactions

  4. 4

    Parag Patil

    $5,358.97 across 11 reported transactions

  5. 5

    Anthony Berg

    $4,500.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as NeuroOne Medical Technologies Corporation's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about NeuroOne Medical Technologies Corporation.

Eminent Spine, LLC

HHI 1889

ulrich medical USA, Inc.

HHI 1891

SiVantage, Inc.

HHI 1887

United Imaging Healthcare North America, Inc.

HHI 1892

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with NeuroOne Medical Technologies Corporation.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download NeuroOne Medical Technologies Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.